All Stories

  1. Platelets in In-stent Restenosis: From Fundamental Role to Possible Prognostic Application
  2. Chemo/radiotherapy-Induced Bone Marrow Niche Alterations
  3. The role of exogenous Fibrinogen in cardiac surgery: stop bleeding or induce cardiovascular disease
  4. Co-existence of mutations in myeloproliferative neoplasms and their clinical significance: a prognostic approach
  5. Prognostic role and therapeutic susceptibility of cathepsin in various types of solid tumor and leukemia: A systematic review
  6. T-Cell Molecular Modulation Responses in Atherosclerosis Anergy
  7. Epigenetic modifications and transcriptional networks in leukemic transformation of HSCs
  8. STAT5: From Pathogenesis Mechanism to Therapeutic Approach in Acute Leukemia
  9. Investigation of JAK2V617F Mutation Prevalence in Patients with Beta Thalassemia Major
  10. Cardiomyopathy in Thalassemia: Quick Review from Cellular Aspects to Diagnosis and Current Treatments
  11. Expression of Blood Cells Associated CD Markers and Cardiovascular Diseases: Clinical Applications in Prognosis
  12. Involvement of circulating inflammatory factors in prognosis and risk of cardiovascular disease
  13. Neutropenia and leukemia development: genetic risk factors and prognosis
  14. Immunomodulation in leukemia: cellular aspects of anti-leukemic properties
  15. CD markers variations in chronic lymphocytic leukemia: New insights into prognosis
  16. Involvement of Interferon‐γ + 874A/T Polymorphism in the Pathogenesis of and Therapeutic Response to Immune Thrombocytopenia
  17. Strategies to inhibit arsenic trioxide‐induced cardiotoxicity in acute promyelocytic leukemia
  18. Role of bone marrow adipocytes in leukemia and chemotherapy challenges
  19. T‐bet transcription factor in cardiovascular disease: Attenuation or inflammation factor?
  20. Endothelial Cells: From Dysfunction Mechanism to Pharmacological Effect in Cardiovascular Disease
  21. Protective role of heat shock transcription factor 1 in heart failure: A diagnostic approach
  22. Signaling-chemokine axis network in brain as a sanctuary site for metastasis
  23. Platelet Activation Polymorphisms in Ischemia
  24. Cellular expression of CD markers in immune thrombocytopenic purpura: implications for prognosis
  25. Role of chemokines in metastatic niche: new insights along with a diagnostic and prognostic approach
  26. Oxidative stress in normal hematopoietic stem cells and leukemia
  27. JAK2V617F allele burden: innovative concept in monitoring of myeloproliferative neoplasms
  28. Cardiovascular disease cause challenge in hematologic cancers
  29. Aberrant DNA Methylation in Chronic Myeloid Leukemia: Cell Fate Control, Prognosis, and Therapeutic Response
  30. How is the relationship between TWIST-1 and BCR-ABL1 gene expressions in chronic myeloid leukaemia patients?
  31. Antioxidant and hepatoprotective effects of Capparis spinosa L. fractions and Quercetin on tert-butyl hydroperoxide- induced acute liver damage in mice
  32. Association between gene polymorphisms and clinical features in idiopathic thrombocytopenic purpura patients
  33. BCR/ABL analysis in myelodysplastic syndromes
  34. Restoration of natural killer cell cytotoxicity in the suppressive tumor microenvironment: novel approaches to treat AML
  35. Evaluation of miR-21 and miR-150 expression in immune thrombocytopenic purpura pathogenesis: a case-control study
  36. Expression of CD markers' in immune thrombocytopenic purpura: prognostic approaches
  37. Sex chromosome changes in leukemia: cytogenetics and molecular aspects
  38. Optimizing peripheral blood stem cells transplantation outcome through amend relapse and graft failure: a review of current literature
  39. Association between beta globin haplotypes, HBBP1 and HMOX1 polymorphisms in relation to HbF among sickle cell anemia patients: a study in Southwest Iran
  40. tree-based methods for differential diagnosis of hematologic disorders
  41. An association study between CHEK2 gene mutations and susceptibility to breast cancer
  42. Prognostic significance of aberrant expression of CD markers in acute lymphoblastic leukemia
  43. Crosstalk between catecholamines and erythropoiesis
  44. The role and clinical implications of the endosteal niche and osteoblasts in regulating leukemia
  45. MicroRNAs as prognostic biomarker and relapse indicator in leukemia
  46. PD-1/PD-L1 as a prognostic factor in leukemia
  47. Estimation of diagnosis and prognosis in ET by assessment of CALR and JAK2V617F mutations and laboratory findings: a meta-analysis
  48. Association between microRNA-21, microRNA-150, and micro-RNA-451 expression and clinical outcome of patients with acute lymphoblastic leukemia
  49. Analysis of DNA methyltransferase 3A gene mutations in patients with Philadelphia-negative myeloproliferative neoplasms
  50. Role of oxidative stress in liver cancer
  51. Sequencing myeloproliferative leukemia exon 10 mutations in iranian patients with breakpoint cluster region-abelson murine leukemia viral oncogene homolog 1-negative myeloproliferative neoplasm
  52. Bone marrow blood vessels: normal and neoplastic niche
  53. High platelet count and high probability of CALR detection in myeloproliferative neoplasms
  54. Acute myeloid leukemia in the vascular niche
  55. Incidence of T315I mutation in BCR/ABL-positive CML and ALL patients
  56. Regulatory role of Megakaryocytes on Hematopoietic Stem Cells Quiescence by CXCL4/PF4 in Bone Marrow Niche
  57. Mesenchymal stem cells as a double-edged sword in suppression or progression of solid tumor cells
  58. Cytogenetic changes of mesenchymal stem cells in the neoplastic bone marrow niche in leukemia
  59. Bone marrow niche in immune thrombocytopenia: a focus on megakaryopoiesis
  60. Role of stem cell factor in the placental niche
  61. Significance of oncogenes and tumor suppressor genes in AML prognosis
  62. A cocktail of repurposed drugs for targeted therapy of glioblastoma
  63. Is Wilms’ tumor gene 1 a useful biomarker for detecting minimal residual disease in chronic myeloid leukemia (BCR-ABL1-p210-positive) patients?
  64. Evaluation of α-Globin Gene Mutations Among Different Ethnic Groups in Khuzestan Province, Southwest Iran
  65. Evaluation of microRNA-146a expression in acute lymphoblastic leukemia
  66. Stem Cell Therapy ‒ Approach for Multiple Sclerosis Treatment
  67. Is There a Relationship Between CXCR4 Gene Expression and Prognosis of Immune Thrombocytopenia in Children?
  68. Signaling and molecular basis of bone marrow niche angiogenesis in leukemia
  69. Coexistence of P190 BCR/ABL transcript and CALR 52-bp deletion in chronic myeloid leukemia blast crisis: a case report
  70. Hepatic metastatic niche: from normal to pre-metastatic and metastatic niche
  71. Prognostic value and clinical significance of TCR rearrangements for MRD monitoring in ALL patients
  72. Survivin and SIRT1: can be two prognostic factors in chronic myeloid leukemia?
  73. Wnt/β-catenin signaling in bone marrow niche
  74. Inhibition of Ras-mediated signaling pathways in CML stem cells
  75. Bone marrow niche in the myelodysplastic syndromes
  76. Central nervous system niche involvement in the leukemia
  77. MicroRNAs in erythropoiesis and red blood cell disorders
  78. Twist as a new prognostic marker in hematological malignancies
  79. The Influence of Polymorphisms in Disease Severity in β-Thalassemia
  80. The bone marrow metastasis niche in retinoblastoma
  81. Immunophenotype, microRNA expression and cytogenetic characterization of acute leukemias of ambiguous lineage
  82. Rare cytogenetic abnormalities and alteration of microRNAs in acute myeloid leukemia and response to therapy
  83. Regulatory effect of chemokines in bone marrow niche
  84. Targeting PI3K/AKT/mTOR network for treatment of leukemia
  85. The mechanistic role of epigenetic in multiple myeloma
  86. Molecular basis of chronic lymphocytic leukemia diagnosis and prognosis
  87. G-CSF induces up-regulation of CXCR4 expression in human hematopoietic stem cells by beta-adrenergic agonist
  88. A case of chronic lymphoblastic leukemia with an abnormal rare karyotype
  89. The role of Pax5 in leukemia: diagnosis and prognosis significance
  90. Hodgkin’s lymphoma after 2-month infliximab therapy: case report
  91. Minimal residual disease in acute lymphoblastic leukemia: optimal methods and clinical relevance, pitfalls and recent approaches
  92. BRAF mutation in hairy cell leukemia
  93. New insights in cellular and molecular aspects of BM niche in chronic myelogenous leukemia
  94. PCR Analysis of IgH and TCR-γ Gene Rearrangements as a Confirmatory Diagnostic Tool for Lymphoproliferative Disorders
  95. The role of notch signaling in bone marrow niche
  96. Induction of Fetal Hemoglobin as a Novel Therapeutic Strategy for β-Hemoglobinopathy
  97. Pattern of immunoglobulin and T-cell receptor-δ/γ gene rearrangements in Iranian children with B-precursor acute lymphoblastic leukemia
  98. Frequency of β-Thalassemia or β-Hemoglobinopathy Carriers Simultaneously Affected with α-Thalassemia in Iran
  99. Prooxidant-Antioxidant Balance and hs-CRP in Patients with β-Thalassemia Major
  100. The role of microRNAs in stemness of cancer stem cells
  101. Meta-analysis of Genetic Polymorphisms and Ophthalmologic Disease Risk in Asian Populations: a Case of DNA Repair XRCC1 Gene
  102. Bone marrow neoplastic niche in leukemia
  103. The roles of miR-146a in the differentiation of Jurkat T-lymphoblasts
  104. The Role of the Nervous System in Hematopoietic Stem Cell Mobilization
  105. Does DNA Methylation Plays a Critical Role in Osteoblastic Differentiation of Mesenchymal Stem Cells (MSCs)?
  106. Expressional Correlation of Human Epidermal Growth Factor Receptor 2, Estrogen/Progesterone Receptor and Protein 53 in Breast Cancer
  107. Evaluation of H3 Histone Methylation and Colony Formation in Erythroid Progenitors Treated with Thalidomide and Sodium Butyrate
  108. JAK2 V617F Mutation in Iranian Patients with Myeloproliferative Neoplasms: Clinical and Laboratory Findings
  109. Biology and Bioinformatics of Myeloma Cell
  110. The first report of homozygous May-Hegglin anomaly E1841K mutation